Explore 10,000+ laboratory markers, in plain English.

also called human herpesvirus 4 (HHV-4)

an antibody related to Epstein-Barr virus

an antibody related to Epstein-Barr virus

also called human herpesvirus 4 (HHV-4)

The Epstein-Barr Virus (EBV) VCA IgG MFI marker is a critical component in the serological assessment for Epstein-Barr virus infection, typically included in a comprehensive EBV panel. This marker specifically measures the Immunoglobulin G (IgG) antibodies against the Viral Capsid Antigen (VCA) of EBV, using a quantitative technique known as Mean Fluorescence Intensity (MFI). VCA is one of the first antigens expressed during an EBV infection, and the presence of IgG antibodies against it is indicative of a past or current infection. The MFI method quantitatively evaluates the amount of these specific IgG antibodies by measuring the average fluorescence intensity of the sample, providing a more precise and sensitive assessment compared to traditional qualitative methods. A positive EBV VCA IgG MFI result generally indicates that the individual has been infected with EBV at some point in their life, as these antibodies are produced during the initial infection and typically persist for life. However, this result does not distinguish between a past resolved infection and an ongoing active infection. Therefore, the EBV VCA IgG MFI values should be interpreted in conjunction with other markers on the EBV panel, such as EBV nuclear antigen (EBNA) and early antigen (EA) antibodies, as well as the patient's clinical presentation and history. This marker plays a vital role in the diagnosis and monitoring of EBV infection, contributing to the understanding of the infection's stage and the patient's immune response, which is essential for appropriate clinical management, especially in cases of suspected mononucleosis, chronic EBV infection, or EBV-related malignancies.

One of the most common viruses worldwide

Total estriol divided by the added amount of estradiol and estrone

a bacterial-derived metabolite with estrogenic and antioxidant activity

The ermB gene, included in the Urinary Tract Infection Panel by RealTime Laboratories, is a significant marker for antibiotic resistance, particularly relevant in the context of urinary tract infections (UTIs). This gene is responsible for conferring resistance to macrolide antibiotics, which include erythromycin, clarithromycin, and azithromycin, through a mechanism known as ribosomal methylation. The presence of the ermB gene in urinary pathogens is a critical factor in determining the appropriate antibiotic therapy, as it indicates the potential ineffectiveness of macrolide antibiotics. Scientifically, the ermB gene encodes a methyltransferase that targets the 23S rRNA component of the bacterial ribosome. The methylation of the ribosome by the enzyme produced by the ermB gene alters the binding site for macrolide antibiotics, thereby preventing these antibiotics from effectively binding to the ribosome and inhibiting protein synthesis. This mechanism of resistance is particularly concerning because macrolides are often used as a first-line treatment for various bacterial infections due to their broad-spectrum activity and low toxicity. In the context of UTIs, the detection of the ermB gene is crucial. UTIs are commonly caused by a range of bacteria, including E. coli, Proteus spp., and Enterococcus spp., which can acquire the ermB gene through horizontal gene transfer. The presence of this gene can significantly limit the therapeutic options available for treating the infection, necessitating the use of alternative antibiotics that the bacteria have not developed resistance to.

An ESR test can help determine if you have a condition that causes inflammation.

Erythrocytes, or red blood cells (RBCs), are generally absent in cerebrospinal fluid (CSF) under normal conditions. Their presence in the CSF often indicates bleeding, trauma, or other pathological processes affecting the central nervous system (CNS). Evaluating erythrocytes in CSF is a crucial step in diagnosing conditions like subarachnoid hemorrhage, traumatic injury, or inflammation. Normal Levels of Erythrocytes in CSF Normal CSF: Contains no erythrocytes under typical conditions (0 cells/μL). What Elevated Erythrocytes in CSF Mean The presence of erythrocytes in CSF can result from one of the following scenarios: 1. Subarachnoid Hemorrhage (SAH) A hallmark of subarachnoid hemorrhage, which is bleeding into the space between the brain and the thin tissues covering it. CSF collected in such cases often appears blood-stained. Differentiation between a true hemorrhage and a traumatic lumbar puncture (see below) is performed using tests such as the xanthochromia test (yellow discoloration due to hemoglobin breakdown). 2. Traumatic Lumbar Puncture Blood contamination during the collection of CSF from a lumbar puncture can lead to the appearance of erythrocytes in the fluid. Typically, the number of erythrocytes decreases across sequentially collected tubes, distinguishing it from a subarachnoid hemorrhage. 3. Inflammatory or Infectious Conditions Severe meningitis or encephalitis can damage blood vessels, allowing erythrocytes to leak into the CSF. 4. Intracranial Hemorrhage Includes bleeding caused by trauma, ruptured aneurysms, or vascular malformations. Often accompanied by elevated CSF protein and signs of increased intracranial pressure. 5. CNS Tumors Certain tumors, such as brain metastases or primary CNS cancers, can invade blood vessels, causing bleeding and resulting in erythrocytes in the CSF. Distinguishing Causes of Erythrocytes in CSF To differentiate causes, additional tests may be performed: Xanthochromia: Indicates older bleeding (hemoglobin breakdown into bilirubin). CSF Protein and Glucose Analysis: Changes can provide clues to accompanying conditions (e.g., high protein in hemorrhages or malignancies). Clinical Implications The presence of erythrocytes in CSF is a critical diagnostic clue. For instance: Persistent erythrocytes in all CSF tubes collected during a lumbar puncture suggest a true hemorrhage. A decreasing number of erythrocytes across tubes is indicative of a traumatic puncture. Next Steps If erythrocytes are detected in CSF, further investigations, such as imaging (CT or MRI) and repeat lumbar punctures, may be necessary to confirm the cause and guide treatment. Always consult a healthcare provider for a comprehensive evaluation in the context of symptoms and other test results.

An aid in distinguishing between primary and secondary polycythemia

a type of bacteria that normally live in the intestines of people and animals.

Can acquire virulent factors and antibiotic resistance

a type of bacteria that normally live in the intestines of people and animals.

Common gut bacterium

E. coli found in urine culture; number indicates infection significance.

Escherichia coli, commonly known as E. coli, is a Gram-negative, rod-shaped bacterium typically found in the lower intestine of warm-blooded animals. Most strains of E. coli are harmless and even beneficial, producing vitamin K2 and preventing the establishment of pathogenic bacteria in the intestine. E. coli is often used as a bio-indicator to test environmental samples for fecal contamination, with different strains being host-specific, which helps determine the source of contamination. Transmission E. coli is transmitted through a fecal-oral route, either directly or indirectly. Symptoms and Pathology There are over 700 antigenic serotypes of E. coli, identified based on O, H, and K antigens. Most humans harbor more than one strain of E. coli simultaneously. While most strains live in the intestines without causing any issues, pathogenic strains can cause various infections in humans, including: Urinary Tract Infections (UTIs) Neonatal Meningitis Intestinal Diseases: ETEC (Enterotoxigenic E. coli): Causes diarrhea in infants and travelers. EIEC (Enteroinvasive E. coli): Causes dysentery-like diarrhea with fever. EPEC (Enteropathogenic E. coli): Causes watery, sometimes bloody, diarrhea, especially in children. EHEC (Enterohemorrhagic E. coli): Causes hemorrhagic diarrhea and/or food poisoning, which may develop into hemolytic uremic syndrome (HUS). This includes the invasive O157strain, which accounts for 80% of EHEC serotypes and produces the verotoxin or Shiga toxin. Strain identification requires molecular techniques that are not readily available in most diagnostic laboratories. Treatment Antibiotics are not useful for treating acute diarrheal illnesses caused by E. coli and may actually increase the risk of developing HUS by up to 17-fold. This occurs because antibiotics can damage the bacteria, causing them to release more toxins. Antibiotics should only be used if a patient is septic, and recommendations should be based on sensitivity results. For an herbal alternative, the Freedom, Cleanse, Restore protocol can be used. Prevention To prevent E. coli infections, avoid any sources of direct or indirect fecal contamination.